Two clinical research professionals and investigators in British Columbia are among the first in Canada to begin a unique pathway to enhancing their skills through a new immersive, internship program. … Read More
Time-limited reimbursement (TLR) is a new Canada’s Drug Agency (CDA) review process whereby a temporary recommendation is issued based on a phase II clinical data assessment, and the final recommendation… Read More
RADIAN’s five-year, $25 million extension will increase support for local organizations and drive progress to help turn the tide on HIV across the region RADIAN will expand geographic focus to… Read More
VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, announced that… Read More
VANCOUVER, BC – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a clinical-stage biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, is pleased to announce that a poster presentation on… Read More
